DBCCF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Jun 24 closing price
Capitalization
42.97M
ESALF
Price
$29.31
Change
-$0.00 (-0.00%)
Updated
Jun 16 closing price
Capitalization
18.29B
Interact to see
Advertisement

DBCCF vs ESALF

Header iconDBCCF vs ESALF Comparison
Open Charts DBCCF vs ESALFBanner chart's image
Decibel Cannabis
Price$0.06
Change-$0.00 (-0.00%)
Volume$167.78K
Capitalization42.97M
Eisai
Price$29.31
Change-$0.00 (-0.00%)
Volume$1.53K
Capitalization18.29B
DBCCF vs ESALF Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DBCCF vs. ESALF commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBCCF is a Hold and ESALF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (DBCCF: $0.06 vs. ESALF: $29.31)
Brand notoriety: DBCCF and ESALF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DBCCF: 264% vs. ESALF: 207%
Market capitalization -- DBCCF: $42.97M vs. ESALF: $18.29B
DBCCF [@Pharmaceuticals: Other] is valued at $42.97M. ESALF’s [@Pharmaceuticals: Other] market capitalization is $18.29B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DBCCF’s FA Score shows that 0 FA rating(s) are green whileESALF’s FA Score has 2 green FA rating(s).

  • DBCCF’s FA Score: 0 green, 5 red.
  • ESALF’s FA Score: 2 green, 3 red.
According to our system of comparison, DBCCF is a better buy in the long-term than ESALF.

Price Growth

DBCCF (@Pharmaceuticals: Other) experienced а +7.42% price change this week, while ESALF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.04%. For the same industry, the average monthly price growth was +12.70%, and the average quarterly price growth was +94.60%.

Reported Earning Dates

DBCCF is expected to report earnings on Apr 22, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.04% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
ESALF($18.3B) has a higher market cap than DBCCF($43M). ESALF has higher P/E ratio than DBCCF: ESALF (46.30) vs DBCCF (37.45). DBCCF YTD gains are higher at: 15.177 vs. ESALF (14.101). ESALF has higher annual earnings (EBITDA): 87.3B vs. DBCCF (6.05M). ESALF has more cash in the bank: 268B vs. DBCCF (3.87M). DBCCF has less debt than ESALF: DBCCF (49.3M) vs ESALF (126B). ESALF has higher revenues than DBCCF: ESALF (744B) vs DBCCF (89.8M).
DBCCFESALFDBCCF / ESALF
Capitalization43M18.3B0%
EBITDA6.05M87.3B0%
Gain YTD15.17714.101108%
P/E Ratio37.4546.3081%
Revenue89.8M744B0%
Total Cash3.87M268B0%
Total Debt49.3M126B0%
FUNDAMENTALS RATINGS
DBCCF vs ESALF: Fundamental Ratings
DBCCF
ESALF
OUTLOOK RATING
1..100
7334
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
11
Undervalued
PROFIT vs RISK RATING
1..100
10089
SMR RATING
1..100
456
PRICE GROWTH RATING
1..100
5254
P/E GROWTH RATING
1..100
3990
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESALF's Valuation (11) in the null industry is in the same range as DBCCF (43). This means that ESALF’s stock grew similarly to DBCCF’s over the last 12 months.

ESALF's Profit vs Risk Rating (89) in the null industry is in the same range as DBCCF (100). This means that ESALF’s stock grew similarly to DBCCF’s over the last 12 months.

ESALF's SMR Rating (6) in the null industry is somewhat better than the same rating for DBCCF (45). This means that ESALF’s stock grew somewhat faster than DBCCF’s over the last 12 months.

DBCCF's Price Growth Rating (52) in the null industry is in the same range as ESALF (54). This means that DBCCF’s stock grew similarly to ESALF’s over the last 12 months.

DBCCF's P/E Growth Rating (39) in the null industry is somewhat better than the same rating for ESALF (90). This means that DBCCF’s stock grew somewhat faster than ESALF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGWRX58.76N/A
N/A
MFS Global Growth R2
NDVRX15.77N/A
N/A
MFS New Discovery Value R1
GLNNX24.40N/A
N/A
MFS Global New Discovery R6
MCEMX13.80N/A
N/A
Martin Currie Emerging Markets IS
AULYX99.70N/A
N/A
American Century Ultra® Y

DBCCF and

Correlation & Price change

A.I.dvisor tells us that DBCCF and AYTU have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBCCF and AYTU's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBCCF
1D Price
Change %
DBCCF100%
+0.18%
AYTU - DBCCF
21%
Poorly correlated
+3.03%
ESALF - DBCCF
15%
Poorly correlated
N/A
CXXIF - DBCCF
2%
Poorly correlated
+0.84%
CRLBF - DBCCF
2%
Poorly correlated
+2.72%
ELTP - DBCCF
-1%
Poorly correlated
+3.31%
More

ESALF and

Correlation & Price change

A.I.dvisor tells us that ESALF and ESAIY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESALF and ESAIY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESALF
1D Price
Change %
ESALF100%
N/A
ESAIY - ESALF
26%
Poorly correlated
+1.34%
DVAX - ESALF
23%
Poorly correlated
+1.43%
KHTRF - ESALF
22%
Poorly correlated
N/A
SHPH - ESALF
22%
Poorly correlated
-1.14%
BLMH - ESALF
21%
Poorly correlated
+1.43%
More